Homocysteine and methionine metabolism in ESRD: A stable isotope study
- 1 September 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 56 (3) , 1064-1071
- https://doi.org/10.1046/j.1523-1755.1999.00624.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Major determinants of hyperhomocysteinemia in peritoneal dialysis patientsKidney International, 1998
- Evidence for disturbed S-adenosylmethionine: S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions?Nephrology Dialysis Transplantation, 1998
- Membrane protein damage and methylation reactions in chronic renal failureKidney International, 1996
- High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patientsKidney International, 1996
- Net uptake of plasma homocysteine by the rat kidney in vivoAtherosclerosis, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremiaKidney International, 1995
- Plasma folate conjugase activities and folate concentrations in patients receiving hemodialysisThe Journal of Nutritional Biochemistry, 1994
- Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine.Journal of Clinical Investigation, 1993
- Methionine metabolism in mammalsThe Journal of Nutritional Biochemistry, 1990